EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Plasma Proteomic Signatures of Glucose Metabolism Disturbances and Early Diabetes

Natalia Zieleniewska, Jacek Jamiołkowski, Anders Malarstig iD, Klev Diamanti, Małgorzata Chlabicz iD, Marcin Kondraciuk iD, Kerhan Woo, Irina Kowalska iD, Karol Kamiński iD

International Journal of Molecular Sciences · 26.04.2026 · 27 (9) · 3844

DOI: 10.3390/ijms27093844 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 26.04.2026. Verfasst von Natalia Zieleniewska und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Population Medicine and Lifestyle Diseases Prevention, Medical University of Białystok, Waszyngtona 15B Street, 15-269 Bialystok, Polan…. Hauptthemen laut MEDLINE: Proteome, Glucose Metabolism Disorders, Blood Proteins. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical University of Bialystok.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Postprandial variability in glucose and protein levels is one of the elements of insulin resistance (IR) and prediabetes, which is an area precursor to type 2 diabetes mellitus (DM). The objective of the study was a comprehensive proteomic analysis according to glucose tolerance in the general population who did not self-report DM or other diseases. We used Olink® Reveal, a novel, high-throughput platform by Olink Proteomics based on their Proximity Extension Assay (PEA), to identify levels of 1034 circulating proteins in small volumes (4 µL) of plasma samples. The study enrolled 508 participants (mean age 52 ± 10.5 years, 47.2% men) from the population-based study, Bialystok PLUS Polish Longitudinal University Study. The study population was categorized according to glucose metabolism in comparison to impaired fasting blood glucose (IFG), impaired glucose tolerance (IGT), and newly diagnosed DM. Analysis of variance (ANOVA) adjusted for age, weight, fat mass, lean mass, and body mass index (BMI), identified 19 proteins significantly associated with categories of glucose tolerance. Of the five markers with the greatest ability to distinguish newly diagnosed diabetes from non-diabetic participants, paralemmin 2 performed best (AUC = 0.81; 77% sensitivity, 75% specificity), whereas furin was the most accurate for detecting any abnormal glucose regulation (AUC = 0.69). A linear regression model adjusted for the same confounding factors showed statistically significant associations between HbA1c levels and 37 proteins. Our findings highlight multiple proteins with significantly different levels across categories of glucose tolerance, especially between the healthy controls and the group with newly diagnosed DM. The consistent patterns of protein level differences, independent of body composition, suggest potential involvement in the progression of glucose metabolism disturbances and provide unique insights into pathomechanisms. These findings identify PALM2, FURIN, PDZK1, ACAA1, and IL18R1 as potential biomarkers of early dysglycemia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProteomeGlucose Metabolism DisordersBlood ProteinsHumansMaleFemaleAdultMiddle AgedBiomarkers

Stichwörter der Autor:innen

biomarkersdiabetes type 2prediabetesproteomic profiling

Substanzen

ProteomeBlood ProteinsBiomarkers

Autor:innen und Institutionen

  • Department of Population Medicine and Lifestyle Diseases Prevention, Medical University of Białystok, Waszyngtona 15B Street, 15-269 Bialystok, Poland.
  • Department of Cardiology and Internal Medicine with Cardiac Intensive Care Unit, Medical University of Białystok, Waszyngtona 15B Street, 15-269 Bialystok, Poland.
  • Department of Medical Epidemiology and Biostatistics, Karolinska Institute, Nobels Road 12A, 171 65 Stockholm, Sweden.
  • Olink, Part of Thermo Fisher Scientific, Salagatan 16A, 753 30 Uppsala, Sweden.
  • Department of Invasive Cardiology and Internal Medicine with Cardiac Intensive Care Unit, Medical University of Białystok, Waszyngtona 15B Street, 15-269 Bialystok, Poland.
  • Department of Internal Medicine and Metabolic Diseases, Medical University of Białystok, Waszyngtona 15B Street, 15-269 Bialystok, Poland.

ORCID-Profile: Anders Malarstig, Małgorzata Chlabicz, Marcin Kondraciuk, Irina Kowalska, Karol Kamiński

Förderung

  • Medical University of Bialystok

Zitieren

APA

Zieleniewska, N., Jamiołkowski, J., Malarstig, A., Diamanti, K., Chlabicz, M., Kondraciuk, M., Woo, K., Kowalska, I., & Kamiński, K. (2026). Plasma Proteomic Signatures of Glucose Metabolism Disturbances and Early Diabetes. International Journal of Molecular Sciences, 27(9), 3844. https://doi.org/10.3390/ijms27093844

Vancouver

Zieleniewska N, Jamiołkowski J, Malarstig A, Diamanti K, Chlabicz M, Kondraciuk M, et al. Plasma Proteomic Signatures of Glucose Metabolism Disturbances and Early Diabetes. International Journal of Molecular Sciences. 2026;27(9):3844. doi:10.3390/ijms27093844

BibTeX
@article{Zieleniewska2026,
  author = {Zieleniewska, Natalia and Jamiołkowski, Jacek and Malarstig, Anders and Diamanti, Klev and Chlabicz, Małgorzata and Kondraciuk, Marcin and Woo, Kerhan and Kowalska, Irina and Kamiński, Karol},
  title = {Plasma Proteomic Signatures of Glucose Metabolism Disturbances and Early Diabetes},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {9},
  pages = {3844},
  doi = {10.3390/ijms27093844}
}
Kostenlos starten →